|
1
|
Yang CS, Wang X, Lu G and Picinich SC:
Cancer prevention by tea: animal studies, molecular mechanisms and
human relevance. Nat Rev Cancer. 9:429–439. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shimizu M, Shirakami Y and Moriwaki H:
Targeting receptor tyrosine kinases for chemoprevention by green
tea catechin, EGCG. Int J Mol Sci. 9:1034–1049. 2008. View Article : Google Scholar
|
|
3
|
Khan N, Afaq F, Saleem M, Ahmad N and
Mukhtar H: Targeting multiple signaling pathways by green tea
polyphenol (-)-epigal-locatechin-3-gallate. Cancer Res.
66:2500–2505. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nandakumar V, Vaid M and Katiyar SK:
(-)-Epigallocatechin-3-gallate reactivates silenced tumor
suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA
methylation and increasing histones acetylation in human skin
cancer cells. Carcinogenesis. 32:537–544. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lund AH and van Lohuizen M: Epigenetics
and cancer. Genes Dev. 18:2315–2335. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hwang YS, Park KK and Chung WY:
Epigallocatechin-3 gallate inhibits cancer invasion by repressing
functional invadopodia formation in oral squamous cell carcinoma.
Eur J Pharmacol. 715:286–295. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen PN, Chu SC, Kuo WH, Chou MY, Lin JK
and Hsieh YS: Epigallocatechin-3 gallate inhibits invasion,
epithelial-mesen-chymal transition and tumor growth in oral cancer
cells. J Agric Food Chem. 59:3836–3844. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ho YC, Yang SF, Peng CY, Chou MY and Chang
YC: Epigallocatechin-3-gallate inhibits the invasion of human oral
cancer cells and decreases the productions of matrix
metallo-proteinases and urokinase-plasminogen activator. J Oral
Pathol Med. 36:588–593. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y, Wang X, Han L, Zhou Y and Sun S:
Green tea polyphenol EGCG reverse cisplatin resistance of A549/DDP
cell line through candidate genes demethylation. Biomed
Pharmacother. 69:285–290. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jin H, Chen JX, Wang H, Lu G, Liu A, Li G,
Tu S, Lin Y and Yang CS: NNK-induced DNA methyltransferase 1 in
lung tumorigenesis in A/J mice and inhibitory effects of
(-)-epigallo-catechin-3-gallate. Nutr Cancer. 67:167–176. 2015.
View Article : Google Scholar :
|
|
12
|
Lee WJ, Shim JY and Zhu BT: Mechanisms for
the inhibition of DNA methyltransferases by tea catechins and
bioflavonoids. Mol Pharmacol. 68:1018–1030. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gao Z, Xu Z, Hung MS, Lin YC, Wang T, Gong
M, Zhi X, Jablon DM and You L: Promoter demethylation of WIF-1 by
epigallocatechin-3-gallate in lung cancer cells. Anticancer Res.
29:2025–2030. 2009.PubMed/NCBI
|
|
14
|
Lai SM, Gu JY, Huang BH, Chang CM and Lee
WL: Preparative separation and purification of epigallocatechin
gallate from green tea extracts using a silica adsorbent containing
β-cyclodextrin. J Chr omatogr B Analyt Technol Biomed Life Sci.
887–888:112–121. 2012. View Article : Google Scholar
|
|
15
|
An IS, An S, Park S, Lee SN and Bae S:
Involvement of microRNAs in epigallocatechin gallate-mediated UVB
protection in human dermal fibroblasts. Oncol Rep. 29:253–259.
2013.
|
|
16
|
Berletch JB, Liu C, Love WK, Andrews LG,
Katiyar SK and Tollefsbol TO: Epigenetic and genetic mechanisms
contribute to telomerase inhibition by EGCG. J Cell Biochem.
103:509–519. 2008. View Article : Google Scholar :
|
|
17
|
Xu Q, Yang CH, Liu Q, Jin XF, Xu XT, Tong
JL, Xiao SD and Ran ZH: Chemopreventive effect of
epigallocatechin-3-gallate (EGCG) and folic acid on the
N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced
gastrointestinal cancer in rat model. J Dig Dis. 12:181–187. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li GX, Chen YK, Hou Z, Xiao H, Jin H, Lu
G, Lee MJ, Liu B, Guan F, Yang Z, Yu A, et al: Pro-oxidative
activities and dose-response relationship of
(-)-epigallocatechin-3-gallate in the inhibition of lung cancer
cell growth: a comparative study in vivo and in vitro.
Carcinogenesis. 31:902–910. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shen X, Zhang Y, Feng Y, Zhang L, Li J,
Xie YA and Luo X: Epigallocatechin-3-gallate inhibits cell growth,
induces apoptosis and causes S phase arrest in hepatocellular
carcinoma by suppressing the AKT pathway. Int J Oncol. 44:791–796.
2014.PubMed/NCBI
|
|
20
|
Lim YC and Cha YY:
Epigallocatechin-3-gallate induces growth inhibition and apoptosis
of human anaplastic thyroid carcinoma cells through suppression of
EGFR/ERK pathway and cyclin B1/CDK1 complex. J Surg Oncol.
104:776–780. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Maruyama T, Murata S, Nakayama K, Sano N,
Ogawa K, Nowatari T, Tamura T, Nozaki R, Fukunaga K and Ohkohchi N:
(-)-Epigallocatechin-3-gallate suppresses liver metastasis of human
colorectal cancer. Oncol Rep. 31:625–633. 2014.
|
|
22
|
Hsu YC and Liou YM: The anti-cancer
effects of (-)-epiga-locathine-3-gallate on the signaling pathways
associated with membrane receptors in MCF-7 cells. J Cell Physiol.
226:2721–2730. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Singh BN, Shankar S and Srivastava RK:
Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms,
perspectives and clinical applications. Biochem Pharmacol.
82:1807–1821. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu X, Zhang DY, Zhang W, Zhao X, Yuan C
and Ye F: The effect of green tea extract and EGCG on the signaling
network in squamous cell carcinoma. Nutr Cancer. 63:466–475. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin HY, Hou SC, Chen SC, Kao MC, Yu CC,
Funayama S, Ho CT and Way TD: (-)-Epigallocatechin gallate induces
Fas/CD95-mediated apoptosis through inhibiting constitutive and
IL-6-induced JAK/STAT3 signaling in head and neck squamous cell
carcinoma cells. J Agric Food Chem. 60:2480–2489. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chang CM, Chang PY, Tu MG, Lu CC, Kuo SC,
Amagaya S, Lee CY, Jao HY, Chen MY and Yang JS: Epigallocatechin
gallate sensitizes CAL-27 human oral squamous cell carcinoma cells
to the anti-metastatic effects of gefitinib (Iressa) via
synergistic suppression of epidermal growth factor receptor and
matrix metalloproteinase-2. Oncol Rep. 28:1799–1807.
2012.PubMed/NCBI
|
|
27
|
Ling Y, Zhang C, Xu Y, Zhu J, Zhu C, Lu M,
Liu Y and Zhou T: Promoter methylation-associated silencing of
p27kip1 gene with metastasis in esophageal squamous cell carcinoma.
Mol Med Rep. 9:1075–1079. 2014.PubMed/NCBI
|
|
28
|
Lee WJ, Shim JY and Zhu BT: Mechanisms for
the inhibition of DNA methyltransferases by tea catechins and
bioflavonoids. Mol Pharmacol. 68:1018–1030. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H,
Welsh W and Yang CS: Tea polyphenol (-)-epigallocatechin-3-gallate
inhibits DNA methyltransferase and reactivates methylation-silenced
genes in cancer cell lines. Cancer Res. 63:7563–7570.
2003.PubMed/NCBI
|
|
30
|
Kato K, Long NK, Makita H, Toida M,
Yamashita T, Hatakeyama D, Hara A, Mori H and Shibata T: Effects of
green tea polyphenol on methylation status of RECK gene and cancer
cell invasion in oral squamous cell carcinoma cells. Br J Cancer.
99:647–654. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Thielecke F and Boschmann M: The potential
role of green tea catechins in the prevention of the metabolic
syndrome-a review. Phytochemistry. 70:11–24. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim HS, Kim MH, Jeong M, Hwang YS, Lim SH,
Shin BA, Ahn BW and Jung YD: EGCG blocks tumor promoter-induced
MMP-9 bexpression via suppression of MAPK and AP-1 activation in
human gastric AGS cells. Anticancer Res. 24:747–753.
2004.PubMed/NCBI
|
|
33
|
Kim J, Zhang X, Rieger-Christ KM,
Summerhayes IC, Wazer DE, Paulson KE and Yee AS: Suppression of Wnt
signaling by the green tea compound (-)-epigallocatechin 3-gallate
(EGCG) in invasive breast cancer cells. Requirement of the
transcriptional repressor HBP1. J Biol Chem. 281:10865–10875. 2006.
View Article : Google Scholar : PubMed/NCBI
|
